FFA
KNSA icon

Farther Finance Advisors’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Farther Finance Advisors’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$111K Sell
1,491
-126
-8% -$9.28K ﹤0.01% 2777
2026
Q2 		$102K Buy
1,617
+81
+5% +$4.2K ﹤0.01% 2685
2026
Q1 		$73.9K Sell
1,536
-18
-1% -$797 ﹤0.01% 2732
2025
Q4 		$64.1K Buy
1,554
+196
+14% +$7.86K ﹤0.01% 2649
2025
Q3 		$52.7K Buy
1,358
+1,159
+582% +$37.7K ﹤0.01% 2406
2025
Q2 		$5.51K Hold
199
– – ﹤0.01% 3323
2025
Q1 		$4.33K Hold
199
– – ﹤0.01% 3123
2024
Q4 		$3.94K Hold
199
– – ﹤0.01% 2758
2024
Q3 		$4.97K Hold
199
– – ﹤0.01% 2650
2024
Q2 		$3.58K Buy
+199
New +$3.73K ﹤0.01% 2543

Other funds holding KNSA

TFA
Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return
JWS
Juncture Wealth Strategies Scottsdale, Arizona $390M AUM 19.15% 1-Year Est. Return
CCAL
City Center Advisors LLC Troy, Michigan $131M AUM 24.02% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

Farther Finance Advisors's KNSA Position: Q3 2026 in Review

Farther Finance Advisors reduced its Kiniksa Pharmaceuticals (KNSA) stake by 7.8% in Q3 2026, selling an estimated $9.28K and leaving 1,491 shares worth $111K. The position accounts for ﹤0.01% of the portfolio, ranked #2777.

Farther Finance Advisors first reported a position in KNSA in Q2 2024 and has held it in 10 quarters since. 8 funds tracked by Wall St. Rank hold KNSA as of Q3 2026.

  • Farther Finance Advisors held 1,491 shares of Kiniksa Pharmaceuticals worth $111K as of Q3 2026.
  • Farther Finance Advisors sold 126 Kiniksa Pharmaceuticals shares in Q3 2026, an estimated $9.28K.
  • Kiniksa Pharmaceuticals made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #2777 holding.
  • Farther Finance Advisors first reported a position in Kiniksa Pharmaceuticals in Q2 2024 and has held it in 10 quarters since.
  • 8 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.